Camrelizumab
Camrelizumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Camrelizumab is under investigation in clinical trial NCT03417895 (SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy).
| Trade Name | Camrelizumab |
| Generic | Camrelizumab |
| Camrelizumab Other Names | Camrelizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Camrelizumab
